Prof Richard Ye, a chair professor of pharmacology and the deputy director of the Institute of Chinese Medical Sciences at the University of Macau (UM), has been chosen as the new associate editor of The FASEB Journal.
In this role he manages all aspects of the peer review and submission decision processes, and will collaborate with the journal’s current group of associate editors, including Dr Helen Blau from Stanford University, Dr Laura Goldsmith from Rutgers New Jersey Medical School, Dr Robert Goldman from Northwestern University, Dr Robert Haselkorn from the University of Chicago, Dr Charles Serhan from Brigham and Women's Hospital, Harvard Institutes of Medicine, and Dr Babette Weksler from Weill Cornell Medical College; as well as the editor-in-chief Dr Thoru Pederson from the University of Massachusetts Medical School.
‘I look forward to working with the journal’s other editors and editorial board,” says Prof Ye when discussing his new appointment. “As the first associate editor based in China, I look forward to helping expand The FASEB Journal’s reach both in terms of expertise and geography.’
Prior to joining UM, Prof Ye was the Zhiyuan Chair Professor and dean of the School of Pharmacy at Shanghai Jiao Tong University. He completed medical school in China and received his PhD degree in cell and integrative biology from Washington University in St Louis. He joined the faculty at The Scripps Research Institute in 1989 and then the University of Illinois at Chicago in 1998. From 1993 to 2008, he served in different positions on various grant review panels at the National Institutes of Health, including the position of a regular member at the Innate Immunity and Inflammation Study Section. Research in his lab focuses on the mechanisms by which cell surface receptors such as G protein-coupled receptors and Toll-like receptors activate innate immune cells and trigger a variety of host-defense actions.
‘We are delighted to bring Richard Ye aboard, both to further enrich and diversify the various research domains of our associate editor tier, but also to help us establish a foothold for The FASEB Journal in China,” says Pederson. ‘We have always received numerous fine papers from Chinese laboratories, but given the tremendous expansion of research institutions underway in the PRC, Dr Ye’s appointment is timely indeed.’
The FASEB Journalis published by the Federation of the American Societies for Experimental Biology (FASEB). It is the world's most cited biology journal according to the Institute for Scientific Information, and has been recognised by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century.
